Recent epidemiological studies highlighted that people with acatalasemia develop T2D [60] and Hait et al. have demonstrated that catalase deletion promotes obesity associated with the impairment of glucose tolerance and insulin sensitivity, increased plasmatic TGs and induced steatosis and inflammation in the liver of Cat−/− mice [61]. This evidence concerns the gene INS and steatosis.